Intuitive's FDA Inquiry: Nightmare or Noise?

Two different views on the FDA's inquiry into the daVinci surgical robot.

Brenton Flynn
Brenton Flynn
Mar 1, 2013 at 5:45PM
Health Care

While Intuitive Surgical (NASDAQ:ISRG) shares have bounced back from Thursday's late day sell-off, investors are still left with more questions than they have answers. In the following video, Brenton Flynn outlines yesterday's news and provides one reason to be optimistic around the outcome of this FDA inquiry. In the spirit of balance, he also offers one fact that gives him pause about investing in the stock.